Understand the source comparison
Glow Stack 40s Age-Specific Protocol: Standard 12-Week Cycle Comparison
Phase 1: Immune Reset 1–4 Thymalin 5–10mg subcutaneous, every other day Restores thymic T-cell differentiation and CD4+/CD8+ balance Begin here. Immune function is the foundation. Elevated systemic inflammation blunts MK-677 IGF-1 response. Phase 2: GH Axis El
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Phase 1: Immune Reset
- 1–4
- Thymalin
- 5–10mg subcutaneous, every other day
- Restores thymic T-cell differentiation and CD4+/CD8+ balance
- Begin here. Immune function is the foundation. Elevated systemic inflammation blunts MK-677 IGF-1 response.
- Phase 2: GH Axis Elevation
- 3–10
- MK-677
- 10–25mg oral, nightly
- Stimulates endogenous GH release via ghrelin receptor agonism
- Overlap with Thymalin weeks 3–4. IGF-1 peaks between weeks 6–8. Water retention is normal.
- Phase 3: Neuroplasticity Support
- 8–12
- Cerebrolysin
- 5–10ml IM/IV, 2–3x weekly
- BDNF/NGF mimetic. Enhances synaptic density and dendritic growth
- Start after IGF-1 stabilises. Cognitive clarity improves within 2–3 weeks. Some researchers extend to 6 weeks.
- Optional Add-On
- 6–12
- Dihexa (low dose)
- 1–2mg oral, 3x weekly
- Potentiates Cerebrolysin via HGF/c-Met pathway activation
- Advanced researchers only. Dihexa amplifies neurotrophin signaling but requires precise dosing.
- The Glow Stack 40s age-specific protocol isn't a simultaneous polypharmacy approach. It's a phased cascade. Thymalin first, because systemic inflammation and poor immune surveillance reduce the efficacy of both MK-677 and Cerebrolysin. MK-677 second, because elevated IGF-1 creates an anabolic environment that supports neuronal repair. Cerebrolysin last, when the body is primed for maximal neuroplasticity response.